- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01291550
Electronic Nose for Diagnosis of Neurodegenerative Diseases Via Breath Samples
The diagnosis of neurodegenerative conditions and ADHD still mostly relies on clinical symptoms as there are no validated, inexpensive, and simple bio- markers available yet. The purpose of this study is to deliver a proof-of-concept for novel biomarkers to identify neurodegenerative conditions and ADHD based on breath testing.
Alveolar breath will be collected from healthy volunteers, patients with extrapyramidal conditions, patients diagnosed with dementia and from ADHD subjects. The discriminative power of a tailor-made Nanoscale Artificial Nose (™NA-NOSE) containing an array of six nanomaterial-based sensors will be tested. Discriminant factor analysis will be applied to the NA-NOSE signals in order to detect statistically significant differences between the sub-populations, and classification success will be estimated using leave-one-out cross-validation. The identification of NA-NOSE patterns will be supported by analyzing the chemical composition of the breath using gas-chromatography in conjunction with mass-spectrometry (GC-MS).
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Haifa, Israel, 31096
- Recruiting
- Cognitive Neurology, Rambam Medical Center
-
Contact:
- Judith Aharon-Peretz, M.D
- Phone Number: 97248543190
- Email: memory@rambam.health.gov.il
-
Contact:
- Michal Levavi, MA.RN
-
Principal Investigator:
- Judith Aharon-Peretz, M.D
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients diagnosed with neurodegenerative conditions
- Healthy subjects
- Subjects diagnosed with ADHD
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Controls
|
Nerodegenerative diseases
Patients with parkinsonism and patients with dementia
|
ADHD
Subjects diagnosed with ADHD
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0196-09
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurodegenerative Diseases
-
University Hospital, Strasbourg, FranceRecruitingNeurodegenerative DisordersFrance
-
First Affiliated Hospital of Fujian Medical UniversityRecruitingNeurodegenerative DisordersChina
-
University of PennsylvaniaAvid RadiopharmaceuticalsRecruiting
-
Fujian Medical University Union HospitalRecruitingNeurodegenerative DisordersChina
-
Imperial College LondonWithdrawn
-
Fujian Medical University Union HospitalRecruitingNeurodegenerative DisorderChina
-
ACADIA Pharmaceuticals Inc.CompletedNeuropsychiatric Symptoms Related to Neurodegenerative DiseaseUnited States, Russian Federation, Serbia, Poland, Georgia, Czechia, Bulgaria, Colombia, Mexico, Romania, South Africa, Ukraine
-
ACADIA Pharmaceuticals Inc.CompletedNeuropsychiatric Symptoms Related to Neurodegenerative DiseaseSerbia, United States, Poland, Georgia, Russian Federation, Bulgaria, Colombia, Czechia, Mexico, Romania, South Africa, Ukraine
-
National Institute of Neurological Disorders and...Completed
-
Istituto Auxologico ItalianoRecruitingNeurodegenerative DiseasesItaly